PS
RGEN icon

Portfolio Strategies’s Repligen RGEN Stock Holding History

Portfolio Strategies’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,260
Closed -$232K – 102
2024
Q1 		$232K Buy
+1,260
New +$240K 0.02% 135

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Portfolio Strategies's RGEN Position: Q2 2024 in Review

Portfolio Strategies sold out of Repligen (RGEN) in Q2 2024, closing a stake of 1,260 shares — an estimated $232K sold.

Portfolio Strategies first reported a position in RGEN in Q1 2024 and held it in 1 quarter. The position peaked at $232K in Q1 2024. 455 funds tracked by Wall St. Rank hold RGEN as of Q2 2024.

  • Portfolio Strategies reported no remaining Repligen position as of Q2 2024 after selling out during the quarter.
  • Portfolio Strategies sold 1,260 Repligen shares in Q2 2024, an estimated $232K.
  • Portfolio Strategies first reported a position in Repligen in Q1 2024 and held it in 1 quarter.
  • Portfolio Strategies's Repligen position peaked at $232K in Q1 2024.
  • 455 funds tracked by Wall St. Rank held Repligen as of Q2 2024.

Based on Portfolio Strategies's 13F filing for Q2 2024, filed 12 Aug 2024.